☆ 4.6 Article

CASE REPORT COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring blaIND-2, blaCIA and blaCcrA

INFECTION AND DRUG RESISTANCE (2022)

The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics

Hyacinth O. Ukuhor

Summary: The COVID-19 pandemic has resulted in high morbidity and mortality rates, with some cases showing resistance to antimicrobials leading to worse outcomes. Antimicrobial-resistant co-infections have been a significant factor in clinically significant mortality. Various factors such as misuse of antimicrobials, international travel, healthcare financing issues, human use/misuse, agricultural production, and climate change are determinants of antimicrobial resistance.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Oncology

Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China

Yixin Zhang et al.

Summary: This study revealed a clonal dissemination of C. indologenes isolates in infections at a tertiary care university hospital in Shanghai, China. Minocycline and trimethoprim-sulfamethoxazole demonstrated favorable in vitro antibacterial effects. However, high resistance rates to beta-lactams and quinolones were primarily due to the presence of beta-lactamase genes (bla(IND), bla(CIA)) and mutations in the QRDRs of GyrA.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience

Sonam Vijay et al.

Summary: A study in India found that 3.6% of hospitalized COVID-19 patients developed secondary bacterial or fungal infections, with a mortality rate of 56.7% among those with secondary infections.

INFECTION AND DRUG RESISTANCE (2021)

添加到收藏夹

Article Immunology

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

Sameer S. Kadri et al.

CLINICAL INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Microbiology

Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)

JT Kirby et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2004)

添加到收藏夹

CASE REPORT COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring blaIND-2, blaCIA and blaCcrA

相关参考文献

The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics

Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China

Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)

导出引文

分享论文